Therapeutic applications of CRISPR-Cas9 gene editing
CRISPR-Cas9 is a gene editing tool used extensively in biological research that is now making its way into clinical therapies. With the first CRISPR therapy obtaining approval by the United States’ Food and Drug Administration (FDA) in late 2023, we look at clinical trials of emerging therapies invo...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2025-12-01
|
| Seri Bilgileri: | Frontiers in Genome Editing |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fgeed.2025.1724291/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|